As is well known, the Covid-19 pandemic has impacted pharmaceutical companies in Indonesia, which have played an active role in handling these extraordinary events. This study aims to determine the effect of company financial performance in terms of profitability ratios, liquidity ratios, and solvency ratios on stock returns in pharmaceutical companies in Indonesia for the 2017-2022 period. A total of eight companies listed on the Indonesia Stock Exchange were examined according to purposive sampling criteria. Observation of data from 48 annual financial reports processed using the Eviews 12 program. The results of this study indicate that Return on Assets (ROA) and Current Assets (CR) have a positive and significant effect on firm value. Earning per Share (EPS) does not affect Stock Return. Meanwhile, the Debt to Equity Ratio significantly negatively affects stock returns.